Methylphenidate ADHD and SUD Study

Methylphenidate ADHD and SUD Study - MASS (Dutch: MAVO)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30648

Enrollment

Registered

2007-07-03

Start date

2008-03-15

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

verslavingsproblematiek Minimal Brain Dysfuntion

Interventions

See study design

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age: 18-65 ADHD according to DSM IV TR criteria Alcohol and/or Cocaine dependence acoording to DSM IV TR criteria. In case of abuse this must be severe in such a way that the patient and his family suffer from severe negative consequenses of this abuse.

Exclusion criteria

Exclusion criteria: severe psychiatric comorbidity (which need interventions first) opiod abuse/dependence severe physical problems cardial problems

Design outcomes

Primary

Measure	Time frame
- ADHD symptomatology	—

Secondary

Measure	Time frame
neuropsychological testing (stop task, contingency test, time reproduction test) substance use craving adverse effects	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)